Gene expression profiling for identification monitoring and treatment of multiple sclerosis
First Claim
1. A method for determining a profile data set for a subject with multiple sclerosis or inflammatory conditions related to multiple sclerosis based on a sample from the subject, the sample providing a source of RNAs, the method comprising:
- using amplification for measuring the amount of RNA corresponding to at least 2 constituents from Table 1 and arriving at a measure of each constituent, wherein the profile data set comprises the measure of each constituent and wherein amplification is performed under measurement conditions that are substantially repeatable.
1 Assignment
0 Petitions
Accused Products
Abstract
A method is provided in various embodiments for determining a profile data set for a subject with multiple sclerosis or inflammatory conditions related to multiple sclerosis based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 2 constituents from Table 1. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.
-
Citations
40 Claims
-
1. A method for determining a profile data set for a subject with multiple sclerosis or inflammatory conditions related to multiple sclerosis based on a sample from the subject, the sample providing a source of RNAs, the method comprising:
-
using amplification for measuring the amount of RNA corresponding to at least 2 constituents from Table 1 and arriving at a measure of each constituent, wherein the profile data set comprises the measure of each constituent and wherein amplification is performed under measurement conditions that are substantially repeatable. - View Dependent Claims (2, 4, 6)
-
-
3. (canceled)
-
5. (canceled)
-
7-9. -9. (canceled)
-
10. A method of characterizing multiple sclerosis or inflammatory conditions related to multiple sclerosis in a subject, based on a sample from the subject, the sample providing a source of RNAs, the method comprising:
assessing a profile data set of a plurality of members, each member being a quantitative measure of the amount of a distinct RNA constituent in a panel of constituents selected so that measurement of the constituents enables characterization of the presumptive signs of a multiple sclerosis, wherein such measure for each constituent is obtained under measurement conditions that are substantially repeatable. - View Dependent Claims (11, 12, 14)
-
13. (cancelled)
-
15-16. -16. (canceled)
-
17. A method for evaluating multiple sclerosis or inflammatory conditions related to multiple sclerosis in a subject based on a first sample from the subject, the sample providing a source of RNAs, the method comprising:
-
deriving from the first sample a first profile data set, the profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA constituent in a panel of constituents selected so that measurement of the constituents enables evaluation of the multiple sclerosis or inflammatory conditions related to multiple sclerosis wherein such measure for each constituent is obtained under measurement conditions that are substantially repeatable; and
producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, and wherein the baseline profile data set is related to the multiple sclerosis or inflammatory conditions related to multiple sclerosis to be evaluated, the calibrated profile data set being a comparison between the first profile data set and the baseline profile data set, thereby providing evaluation of the multiple sclerosis or inflammatory conditions related to multiple sclerosis of the subject. - View Dependent Claims (18, 19, 20, 25, 26, 27, 28, 29, 30, 31, 39)
-
-
21-24. -24. (canceled)
-
32-38. -38. (canceled)
-
40-179. -179. (canceled)
Specification